|
HIBADH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.95770000000529E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.049200E-04 |
| Normal-vs-Stage2 |
7.350400E-02 |
| Normal-vs-Stage3 |
1.997580E-04 |
| Normal-vs-Stage4 |
1.67436999999326E-05 |
| Stage1-vs-Stage2 |
9.494000E-01 |
| Stage1-vs-Stage3 |
6.281700E-02 |
| Stage1-vs-Stage4 |
9.084700E-03 |
| Stage2-vs-Stage3 |
2.137000E-01 |
| Stage2-vs-Stage4 |
7.030300E-02 |
| Stage3-vs-Stage4 |
5.006200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.151300E-04 |
| Normal-vs-AfricanAmerican |
3.377300E-04 |
| Normal-vs-Asian |
1.523400E-01 |
| Caucasian-vs-AfricanAmerican |
3.350600E-01 |
| Caucasian-vs-Asian |
4.423600E-01 |
| AfricanAmerican-vs-Asian |
6.082400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.839020E-04 |
| Normal-vs-Female |
7.631300E-04 |
| Male-vs-Female |
4.678600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.95239999999775E-05 |
| Normal-vs-Extreme_Weight |
2.776600E-04 |
| Normal-vs-Obese |
1.203110E-03 |
| Normal-vs-Extreme_Obese |
6.956400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.881200E-01 |
| Normal_Weight-vs-Obese |
2.275000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.129600E-02 |
| Extreme_Weight-vs-Obese |
5.774200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.570200E-02 |
| Obese-vs-Extreme_Obese |
2.022600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.579300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.593730E-04 |
| Normal-vs-Age(61-80Yrs) |
5.955900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.001200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.424600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.581600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.499410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.589400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.138800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.657200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.048470E-02 |
| Normal-VS-Type2 PRCC |
1.039630E-04 |
| Normal-VS-KIRP CIMP |
1.57049999671699E-08 |
| Normal-VS-Unclassified PRCC |
3.261700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.624030E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.34909999949251E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
3.570000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.81469999999529E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
7.364800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.542000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.387900E-04 |
| Normal-vs-N1 |
4.08619999999749E-05 |
| Normal-vs-N2 |
3.796700E-04 |
| N0-vs-N1 |
1.058160E-01 |
| N0-vs-N2 |
6.161700E-03 |
| N1-vs-N2 |
6.342200E-01 |
|
|
